• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压的初始治疗:对生活质量的考量

Initial therapy in hypertension: quality-of-life considerations.

作者信息

Hollenberg N K

出版信息

J Hypertens Suppl. 1987 Feb;5(1):S3-7.

PMID:3553494
Abstract

Treatment has one of two fundamental goals, relief of symptoms or a change in natural history. In general, a treatment goal of symptom relief is easier to achieve. One treats each day for symptoms that day, and a patient's compliance is maintained when symptoms are relieved. Treatment that has as its goal a change in natural history, without providing symptom relief, is fundamentally more difficult: one treats today for events that might occur tomorrow--or months or years later. The revolution in what we have available for treatment has been accompanied by an evolution in expectations. In the area of hypertension the expectations are stringent. The physician cannot provide the patient with symptom relief, because there are no symptoms directly attributable to the hypertension--although few individuals are free of symptoms. The short-term goal is to control the high blood pressure at a minimal cost in adverse reactions; the long-term goal is to change natural history. Two decades ago antihypertensive therapy was restricted to very severe hypertension. The available agents were difficult to use, and they produced substantial side effects. Over the past several decades each wave of new agents has provided some improvement in efficacy, but primarily a reduction in the frequency and severity of adverse reactions. Today, at a time when we often wish to treat mild hypertension, the goal is to have patients feel as well on treatment as they do off it. A progressive reduction in the frequency and severity of central nervous system side effects is one of the major features of the evolution of therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

治疗有两个基本目标之一,即缓解症状或改变疾病自然进程。一般来说,缓解症状的治疗目标更容易实现。人们针对当天的症状进行每日治疗,当症状缓解时患者的依从性得以维持。以改变自然进程为目标而不缓解症状的治疗,从根本上来说更具难度:人们当下治疗是为了预防明天——或数月或数年之后可能发生的情况。我们可用于治疗的手段发生了变革,与此同时期望也有所演变。在高血压领域,期望是严格的。医生无法为患者缓解症状,因为没有直接归因于高血压的症状——尽管几乎没有人没有症状。短期目标是以最小的不良反应代价控制高血压;长期目标是改变自然进程。二十年前,抗高血压治疗仅限于非常严重的高血压。可用药物难以使用,且会产生大量副作用。在过去几十年里,每一波新药物都在疗效上有所改善,但主要是不良反应的频率和严重程度有所降低。如今,在我们常常希望治疗轻度高血压的时代,目标是让患者在接受治疗时和未接受治疗时感觉一样良好。中枢神经系统副作用的频率和严重程度逐步降低是治疗演变的主要特征之一。(摘要截选至250词)

相似文献

1
Initial therapy in hypertension: quality-of-life considerations.高血压的初始治疗:对生活质量的考量
J Hypertens Suppl. 1987 Feb;5(1):S3-7.
2
Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.依普罗沙坦能为轻至中度原发性高血压患者提供安全有效的长期血压控制。
Curr Med Res Opin. 2001;17(1):8-17.
3
Utility of behavioral science techniques in assessing adverse effects of antihypertensive agents.
Am J Kidney Dis. 1987 Jul;10(1 Suppl 1):61-5.
4
Captopril as a replacement for multiple therapy in hypertension: a controlled study.卡托普利替代多种药物治疗高血压的对照研究。
J Hypertens Suppl. 1985 Nov;3(2):S155-8.
5
The future of antihypertensive treatment.抗高血压治疗的未来。
Am J Ther. 2007 Mar-Apr;14(2):121-34. doi: 10.1097/01.pap.0000249915.12185.58.
6
Antihypertensive therapy and quality of life.
Am Fam Physician. 1987 Mar;35(3):221-6.
7
[Retrospective studies and prospects of therapy for hypertension].[高血压治疗的回顾性研究与展望]
Herz. 1995 Dec;20(6):370-89.
8
Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction.非洛地平-美托洛尔复方片剂:在显著降低血压的情况下维持与健康相关的生活质量。
Am J Hypertens. 2005 Oct;18(10):1313-9. doi: 10.1016/j.amjhyper.2005.04.017.
9
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
10
A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.对3742例加拿大高血压患者进行的喹那普利上市后监测评估:ACCEPT研究。喹那普利加拿大临床评估与患者教育。
Clin Ther. 1994 Sep-Oct;16(5):838-53.

引用本文的文献

1
Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis.青光眼诊断时生活质量与临床症状及体征的相关性。
Trans Am Ophthalmol Soc. 1998;96:753-812.
2
The effect of antihypertensive treatment on the quality of later years.降压治疗对晚年生活质量的影响。
Drugs Aging. 1993 Jan-Feb;3(1):26-39. doi: 10.2165/00002512-199303010-00003.
3
Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group.
地尔硫䓬和美托洛尔对血压、不良症状及总体健康状况的影响。瑞典地尔硫䓬-美托洛尔多中心研究小组。
Eur J Clin Pharmacol. 1991;40(5):453-60. doi: 10.1007/BF00315222.